From new drug discovery to production process improvements, innovation is at the heart of the pharmaceutical industry. As challenges mount, new solutions and effective collaboration methods are critical success factors. Leading pharmaceutical companies choose Brightidea to differentiate between products and sustain competitive advantage.
Brightidea has helped leading pharmaceutical companies find innovations with real impact on their business.
Bristol-Meyers Squibb identified cost saving and process improvements in multiple business areas and runs an enterprise structure of WebStorm communities to foster innovation company-wide.
As new drug development becomes increasingly complex and expensive and R&D budgets shrink, pharmaceutical companies need to continually explore new ways to create incremental innovations and indentify cost savings costs. Tightening regulations and growing competition from generic drug manufacturers as patents expire increase the pressure to keep product pipelines full. Industry leaders have identified cross-organizational collaborations as an effective new approach to collect new ideas and continually innovate their business.
Brightidea's innovation management software is used by the leading pharmaceutical companies around the world to collect and collaborate on ideas for disruptive and incremental innovations that drive business growth and increase shareholder value.
Contact us today for more information about how Brightidea can help you innovate successfully.